| Chimeric peptidomimetic antibiotics against Gram-negative bacteria A Luther, M Urfer, M Zahn, M Müller, SY Wang, M Mondal, A Vitale, ... Nature 576 (7787), 452-458, 2019 | 274 | 2019 |
| Small‐Molecule Inhibitors of GSK‐3: Structural Insights and Their Application to Alzheimer′ s Disease Models T Kramer, B Schmidt, F Lo Monte International journal of Alzheimer’s disease 2012 (1), 381029, 2012 | 179 | 2012 |
| A peptidomimetic antibiotic targets outer membrane proteins and disrupts selectively the outer membrane in Escherichia coli M Urfer, J Bogdanovic, FL Monte, K Moehle, K Zerbe, U Omasits, ... Journal of Biological Chemistry 291 (4), 1921-1932, 2016 | 110 | 2016 |
| Structure-based optimization of oxadiazole-based GSK-3 inhibitors FL Monte, T Kramer, J Gu, M Brodrecht, J Pilakowski, A Fuertes, ... European journal of medicinal chemistry 61, 26-40, 2013 | 63 | 2013 |
| Identification of Glycogen Synthase Kinase-3 Inhibitors with a Selective Sting for Glycogen Synthase Kinase-3α F Lo Monte, T Kramer, J Gu, UR Anumala, L Marinelli, V La Pietra, ... Journal of Medicinal Chemistry 55 (9), 4407-4424, 2012 | 62 | 2012 |
| Small molecule kinase inhibitors for LRRK2 and their application to Parkinson's disease models T Kramer, F Lo Monte, S Göring, GM Okala Amombo, B Schmidt ACS chemical neuroscience 3 (3), 151-160, 2012 | 54 | 2012 |
| 2-Styrylindolium based fluorescent probes visualize neurofibrillary tangles in Alzheimer’s disease J Gu, UR Anumala, F Lo Monte, T Kramer, RH Haußen, J Hölzer, ... Bioorganic & Medicinal Chemistry Letters, 2012 | 33 | 2012 |
| Synthesis and biological evaluation of glycogen synthase kinase 3 (GSK-3) inhibitors: An fast and atom efficient access to 1-aryl-3-benzylureas F Lo Monte, T Kramer, A Boländer, B Plotkin, H Eldar-Finkelman, ... Bioorganic & Medicinal Chemistry Letters 21 (18), 5610-5615, 2011 | 32 | 2011 |
| Fluorescent rhodanine-3-acetic acids visualize neurofibrillary tangles in Alzheimer’s disease brains UR Anumala, J Gu, F Lo Monte, T Kramer, RH Haußen, J Hölzer, ... Bioorganic & Medicinal Chemistry, 2013 | 16 | 2013 |
| Modification of a promiscuous inhibitor shifts the inhibition from γ-secretase to FLT-3 GMO Amombo, T Kramer, F Lo Monte, S Göring, M Fach, S Smith, S Kolb, ... Bioorganic & Medicinal Chemistry Letters, 2012 | 14 | 2012 |
| 2-BENZYLSULFANYL [1, 3, 4]-OXADIAZOLE DERIVATIVES, AND MEDICAL USE THEREOF B Schmidt, F Lo Monte, H Eldar-Finkelmann, F Van Leuven, T Kramer, ... WO Patent 2,013,007,663, 2013 | | 2013 |
| Design, Synthese und Optimierung von GSK-3-Inhibitoren und ihre Evaluation in Modellen der Alzheimer-Demenz F Lo Monte Technische Universität, 2012 | | 2012 |
| P2‐535: GSK‐3 inhibitors in Alzheimer's disease F Lo Monte, T Kramer, A Boländer, B Plotkin, H Elgar‐Finkelman Alzheimer's & Dementia 7, S483-S483, 2011 | | 2011 |
| GSK-3 inhibitors in Alzheimer's disease F Lo Monte, T Kramer, A Boländer, B Plotkin, H Elgar-Finkelman Alzheimer's and Dementia 7 (4), 4, 2011 | | 2011 |
| Anhydrous impregnation of high strength and temperature stable aramide fibers in supercritical CO2 - first dyeing test K Knopf et al Textilveredlung, 4-9, 2008 | | 2008 |
